Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jun 9:16:1699-1708.
doi: 10.2147/COPD.S300779. eCollection 2021.

Atypical Pathogen Distribution in Chinese Hospitalized AECOPD Patients: A Multicenter Cross-Sectional Study

Chenye Feng  1 , Mingtao Xu  1 , Jian Kang  1 , Fuqiang Wen  2 , Yahong Chen  3 , Jing Zhang  4 , Wei Xiao  5 , Zhonghe Zhang  6 , Lan Yang  7 , Jianmin Huo  8 , Jie Cao  9 , Li Zhao  10 , Shuyue Xia  11 , Yan Yin  1 , Wei Wang  1
Affiliations
Multicenter Study

Atypical Pathogen Distribution in Chinese Hospitalized AECOPD Patients: A Multicenter Cross-Sectional Study

Chenye Feng et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Purpose: The proportion of atypical pathogens in patient with AECOPD within mainland China is unknown. The objectives of this study were to determine the distribution of atypical pathogens among Chinese patients with AECOPD, to evaluate the clinical characteristics of different atypical pathogen infections, and to compare different detection methods for atypical pathogens.

Patients and methods: Specimens were collected from patients with AECOPD from March 2016 to November 2018 at eleven medical institutions in eight cities in China. Double serum, sputum, and urine samples were obtained from 145 patients. Serological and nucleic acid tests were used to assess for Mycoplasma pneumonia and Chlamydia pneumoniae; serological, urinary antigen, and nucleic acid tests were applied to detect Legionella pneumophila. The clinical characteristics of atypical pathogen-positive and -negative groups were also compared.

Results: The overall positivity rate for Mycoplasma pneumoniae was 20.69% (30/145), with the highest rate being 20.00% (29/145) when determined by passive agglutination.The overall positive rates for Chlamydia pneumoniae and Legionella pneumophila were 29.66% (43/145) and 10.34% (15/145), respectively. The most common serotype of Legionella pneumophila was type 6. The maximum hospitalized body temperature, ratio of eosinophils, C-reactive protein (CRP) level, and procalcitonin (PCT) level of the Mycoplasma pneumoniae-positive group were significantly higher than those of the Mycoplasma pneumoniae-negative group. Patients in the Chlamydia pneumoniae-positive group smoked more, had higher proportions of comorbidities and frequent aggravations in the previous two years than those in the Chlamydia pneumoniae-negative group. Furthermore, the forced expiratory volume in one second to forced vital capacity (FEV1/FVC) ratio assessment of lung function was higher, and the concentration of arterial blood bicarbonate (HCO3-) was lower in the Legionella pneumophila-positive group than in the Legionella pneumophila-negative group.

Conclusion: Overall, atypical pathogens play an important role in AECOPD. Regarding the testing method, serological testing is a superior method to nucleic acid testing.

Keywords: COPD; Chlamydia pneumoniae; Legionella pneumophila; Mycoplasma pneumoniae; exacerbations.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Lõpez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi: 10.1111/resp.12660 - DOI - PubMed
    1. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002;121(3):688–696. doi: 10.1378/chest.121.3.688 - DOI - PubMed
    1. Soler-Cataluña JJ, Má MG, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi: 10.1136/thx.2005.040527 - DOI - PMC - PubMed
    1. Mackay AJ, Hurst JR. COPD exacerbations. causes, prevention, and treatment. Immunol Allergy Clin North Am. 2013;33(1):95–115. doi: 10.1016/j.iac.2012.10.006 - DOI - PubMed
    1. Domenech A, Puig C, Martí S, et al. Infectious etiology of acute exacerbations insevere COPD patients. J Infect. 2013;67(6):516–523. doi: 10.1016/j.jinf.2013.09.003 - DOI - PubMed

Publication types

MeSH terms